Part of the Pharmacy and Pharmaceutical Sciences Commons

Works by Anne Muhleisen in Pharmacy and Pharmaceutical Sciences

2017

Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women, Clayton English, Anne Muhleisen, Jose A. Rey
Faculty Articles

Link

Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women, Clayton English, Anne Muhleisen, Jose A. Rey
Faculty Articles

Link